Private Institute Briefs

After seeing countless sentimental ads of big-eyed puppies and kittens distributed by animal rights activists, the Washington, D.C.-based Foundation for Biomedical Research has responded with a few emotional ads of its own. ‘Thanks to animal research, they’ll be able to protest 20.8 years longer,” reads one ad that depicts an angry crowd demonstrating against the use of laboratory animals. Another ad shows slides of cancer cells, diseased heart tissue, and the AIDS virus benea

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

After seeing countless sentimental ads of big-eyed puppies and kittens distributed by animal rights activists, the Washington, D.C.-based Foundation for Biomedical Research has responded with a few emotional ads of its own. ‘Thanks to animal research, they’ll be able to protest 20.8 years longer,” reads one ad that depicts an angry crowd demonstrating against the use of laboratory animals. Another ad shows slides of cancer cells, diseased heart tissue, and the AIDS virus beneath the headline, “If we stop animal research, who’ll stop the real killers?” The ads were created free of charge by the New York advertising firm Bozell, Jacobs, Kenyon & Eckhardt after art director David Wojdyla realized the value of biomedical research was getting buried in the animal rights debate. Since then, the foundation has bought space for the ads in several national newspapers, including the Washington Post, and has made them available for use by its ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies